Insiders Xenon Pharmaceuticals Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:03:20 15/05/2024 pm IST			5-day change	1st Jan Change
41.42 ^USD	+2.06%		-2.92%	-9.52%

10/05	Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating	MT
09/05	Xenon Pharmaceuticals Q1 Net Loss Narrows	MT

Xenon Pharmaceuticals Inc. Announces Board Resignations	20/04	CI
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	09/03	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	09/03	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $758,983, According to a Recent SEC Filing	16/12	MT
Insider Sell: Xenon Pharmaceuticals	25/23/25	MT
Xenon Pharmaceuticals Inc. Announces Board Appointments	09/23/09	CI
Insider Sell: Xenon Pharmaceuticals	30/23/30	MT
Xenon Pharmaceuticals Inc. Announces Appointment of Andrea Difabio as Chief Legal Officer and Corporate Secretary	07/22/07	CI
Insider Sell: Xenon Pharmaceuticals	08/22/08	MT
Insider Sell: Xenon Pharmaceuticals	03/22/03	MT
Insider Sell: Xenon Pharmaceuticals	17/22/17	MT
Insider Sell: Xenon Pharmaceuticals	17/22/17	MT
Xenon Pharmaceuticals Inc. Announces Michael Hayden Will Not Stand for Re-Election as Member of Board	02/22/02	CI
Insider Sell: Xenon Pharmaceuticals	09/22/09	MT
Insider Sell: Xenon Pharmaceuticals	09/22/09	MT
Insider Sell: Xenon Pharmaceuticals	09/22/09	MT
Xenon Pharmaceuticals Inc. Appoints Christopher Kenney, M.D. as Chief Medical Officer	23/21/23	CI
Xenon Pharmaceuticals Inc. Announces Board Appointments	04/21/04	CI
Xenon Pharmaceuticals Inc Elects Ian Mortimer as Chief Executive Officer	04/21/04	CI
Insider Trends: Xenon Pharmaceuticals Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	02/21/02	MT

No results for this search